BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29149180)

  • 1. Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
    Subarnbhesaj A; Miyauchi M; Chanbora C; Mikuriya A; Nguyen PT; Furusho H; Ayuningtyas NF; Fujita M; Toratani S; Takechi M; Niida S; Takata T
    PLoS One; 2017; 12(11):e0187092. PubMed ID: 29149180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
    Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
    Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of different osteoclast phenotypes in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Hou Y; Long W; Ye S; Wang Z
    Oncol Rep; 2018 Mar; 39(3):1043-1051. PubMed ID: 29286135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
    Quan J; Du Q; Hou Y; Wang Z; Zhang J
    Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma].
    Sha D; He YJ
    Ai Zheng; 2006 Feb; 25(2):229-34. PubMed ID: 16480593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome of patients with oral squamous cell carcinoma using vascular invasion and the strongly positive expression of vascular endothelial growth factors.
    Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Asahina I; Ikeda T
    Oral Oncol; 2011 Jul; 47(7):588-93. PubMed ID: 21602095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral squamous cell carcinomas stimulate osteoclast differentiation.
    Deyama Y; Tei K; Yoshimura Y; Izumiyama Y; Takeyama S; Hatta M; Totsuka Y; Suzuki K
    Oncol Rep; 2008 Sep; 20(3):663-8. PubMed ID: 18695921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1/TβRII/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages.
    Sun H; Miao C; Liu W; Qiao X; Yang W; Li L; Li C
    Biochem Biophys Res Commun; 2018 Mar; 497(2):583-590. PubMed ID: 29462614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
    Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vascular endothelial growth factor-C and -D on osteoclast differentiation and function in human peripheral blood mononuclear cells.
    Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
    Arch Oral Biol; 2013 Jan; 58(1):35-41. PubMed ID: 22771550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flt-1 signaling in macrophages promotes glioma growth in vivo.
    Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
    Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo.
    Ren WP; Markel DC; Zhang R; Peng X; Wu B; Monica H; Wooley PH
    Biomaterials; 2006 Oct; 27(30):5161-9. PubMed ID: 16814378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
    Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
    Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCP-1 as a potential target to inhibit the bone invasion by oral squamous cell carcinoma.
    Quan J; Morrison NA; Johnson NW; Gao J
    J Cell Biochem; 2014 Oct; 115(10):1787-98. PubMed ID: 24905457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fms-like tyrosine kinase (Flt)-4 signaling participates in osteoclast differentiation in osteopetrotic (op/op) mice.
    Tsuka N; Motokawa M; Kaku M; Kawata T; Fujita T; Ohtani J; Koseki H; Sunagawa H; Matsuda Y; Abedini S; Hayashi H; Tanne K
    Biomed Res; 2009 Feb; 30(1):31-7. PubMed ID: 19265261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
    Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
    Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.